135 related articles for article (PubMed ID: 38526651)
1. Ginsenoside Rg5 inhibits glioblastoma by activating ferroptosis via NR3C1/HSPB1/NCOA4.
Zhang G; Hu J; Li A; Zhang H; Guo Z; Li X; You Z; Wang Y; Jing Z
Phytomedicine; 2024 Jul; 129():155631. PubMed ID: 38640858
[TBL] [Abstract][Full Text] [Related]
2. Ginsenoside Rk1 bioactivity: a systematic review.
Elshafay A; Tinh NX; Salman S; Shaheen YS; Othman EB; Elhady MT; Kansakar AR; Tran L; Van L; Hirayama K; Huy NT
PeerJ; 2017; 5():e3993. PubMed ID: 29158964
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological activities of ginsenoside Rg5 (Review).
Liu MY; Liu F; Gao YL; Yin JN; Yan WQ; Liu JG; Li HJ
Exp Ther Med; 2021 Aug; 22(2):840. PubMed ID: 34149886
[TBL] [Abstract][Full Text] [Related]
4. Ginsenoside Rg5 as an anticancer drug: a comprehensive review on mechanisms, structure-activity relationship, and prospects for clinical advancement.
Elsaman T; Muddathir AM; Mohieldin EAM; Batubara I; Rahminiwati M; Yamauchi K; Mohamed MA; Asoka SF; Büsselberg D; Habtemariam S; Sharifi-Rad J
Pharmacol Rep; 2024 Apr; 76(2):287-306. PubMed ID: 38526651
[TBL] [Abstract][Full Text] [Related]
5. Ginsenoside Rg5: A Review of Anticancer and Neuroprotection with Network Pharmacology Approach.
Gao XF; Zhang JJ; Gong XJ; Li KK; Zhang LX; Li W
Am J Chin Med; 2022; 50(8):2033-2056. PubMed ID: 36222119
[TBL] [Abstract][Full Text] [Related]
6. Folic acid-modified ginsenoside Rg5-loaded bovine serum albumin nanoparticles for targeted cancer therapy in vitro and in vivo.
Dong Y; Fu R; Yang J; Ma P; Liang L; Mi Y; Fan D
Int J Nanomedicine; 2019; 14():6971-6988. PubMed ID: 31507319
[TBL] [Abstract][Full Text] [Related]
7. Ginsenoside Rg5 induces apoptosis and autophagy via the inhibition of the PI3K/Akt pathway against breast cancer in a mouse model.
Liu Y; Fan D
Food Funct; 2018 Nov; 9(11):5513-5527. PubMed ID: 30207362
[TBL] [Abstract][Full Text] [Related]
8. Ginsenosides Inhibit the Proliferation of Lung Cancer Cells and Suppress the Rate of Metastasis by Modulating EGFR/VEGF Signaling Pathways.
Yu X; Wang Q; Dai Z
J Oleo Sci; 2024; 73(2):219-230. PubMed ID: 38311411
[TBL] [Abstract][Full Text] [Related]
9. The Preparation of Ginsenoside Rg5, Its Antitumor Activity against Breast Cancer Cells and Its Targeting of PI3K.
Liu Y; Fan D
Nutrients; 2020 Jan; 12(1):. PubMed ID: 31963684
[TBL] [Abstract][Full Text] [Related]
10. The CsTM alters multicellular trichome morphology and enhances resistance against aphid by interacting with CsTIP1;1 in cucumber.
Yang S; Xue S; Shan L; Fan S; Sun L; Dong Y; Li S; Gao Y; Qi Y; Yang L; An M; Wang F; Pang J; Zhang W; Weng Y; Liu X; Ren H
J Adv Res; 2024 Apr; ():. PubMed ID: 38609051
[TBL] [Abstract][Full Text] [Related]
11. Ancient herbal therapy: A brief history of
Potenza MA; Montagnani M; Santacroce L; Charitos IA; Bottalico L
J Ginseng Res; 2023 May; 47(3):359-365. PubMed ID: 37252279
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in oridonin derivatives with anticancer activity.
Sobral PJM; Vicente ATS; Salvador JAR
Front Chem; 2023; 11():1066280. PubMed ID: 36846854
[TBL] [Abstract][Full Text] [Related]
13. Natural Products as Anticancer Agents: Current Status and Future Perspectives.
Naeem A; Hu P; Yang M; Zhang J; Liu Y; Zhu W; Zheng Q
Molecules; 2022 Nov; 27(23):. PubMed ID: 36500466
[TBL] [Abstract][Full Text] [Related]
14. Ginsenosides in cancer: A focus on the regulation of cell metabolism.
Yao W; Guan Y
Biomed Pharmacother; 2022 Dec; 156():113756. PubMed ID: 36228372
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
